...BRCA1 breast cancer gene mutation and the risks it poses to women who test positive for it. The evaluation used data col...
...BRCA1/2 mutations. Since Brit1 is a key regulator in DDR and HR repair, we believe that we can develop a similar strateg...
...BRCA1 or BRCA2 were excluded. Cases and their relatives completed structured questionnaires assessing breast cancer risk...
...BRCA1 vs. higher BRCA1 (46 vs.33 months, p = 0.03). High BRCA1 was predictive of poorer OS specifically in patients with...
...BRCA1/2 mutation. We evaluated 241 consecutive women with a BRCA1 or BRCA2 mutation who were enrolled in the surveillanc...
The present study prospectively examined change in diet and physical activity behaviors in 115 women undergoing BRCA1/2 ...
For newly diagnosed breast cancer patients, BRCA1/2 genetic counseling (GC) and/or testing has the greatest potential to...
...BRCA1-mutated and basal-like cancers indicates that disruption of BRCA1 may be an essential common initial pathogenic ev...
...BRCA1/2 and subsequent risk reduction decisions after receiving a positive mutation result. Fifty nine women between the...
...BRCA1-associated breast cancers are triple-negative and basal-like; the extent to which the BRCA1 pathway contributes to...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
